131 related articles for article (PubMed ID: 34118720)
1. Benzofuranyl-2-imidazoles as imidazoline I
Rodriguez-Arévalo S; Bagán A; Griñán-Ferré C; Vasilopoulou F; Pallàs M; Brocos-Mosquera I; Callado LF; Loza MI; Martínez AL; Brea J; Pérez B; Molins E; De Jonghe S; Daelemans D; Radan M; Djikic T; Nikolic K; Hernández-Hernández E; García-Fuster MJ; García-Sevilla JA; Escolano C
Eur J Med Chem; 2021 Oct; 222():113540. PubMed ID: 34118720
[TBL] [Abstract][Full Text] [Related]
2. Bicyclic α-Iminophosphonates as High Affinity Imidazoline I
Abás S; Rodríguez-Arévalo S; Bagán A; Griñán-Ferré C; Vasilopoulou F; Brocos-Mosquera I; Muguruza C; Pérez B; Molins E; Luque FJ; Pérez-Lozano P; de Jonghe S; Daelemans D; Naesens L; Brea J; Loza MI; Hernández-Hernández E; García-Sevilla JA; García-Fuster MJ; Radan M; Djikic T; Nikolic K; Pallàs M; Callado LF; Escolano C
J Med Chem; 2020 Apr; 63(7):3610-3633. PubMed ID: 32150414
[TBL] [Abstract][Full Text] [Related]
3. Imidazoline-1 receptor ligands as apoptotic agents: pharmacophore modeling and virtual docking study.
Nikolic K; Veljkovic N; Gemovic B; Srdic-Rajic T; Agbaba D
Comb Chem High Throughput Screen; 2013 May; 16(4):298-319. PubMed ID: 23360165
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of imidazoline receptor ligands on basal and kainic acid-induced neurotoxic signalling in mice.
Keller B; García-Sevilla JA
J Psychopharmacol; 2016 Sep; 30(9):875-86. PubMed ID: 27302941
[TBL] [Abstract][Full Text] [Related]
5. Disease-modifying treatment with I
Vasilopoulou F; Rodríguez-Arévalo S; Bagán A; Escolano C; Griñán-Ferré C; Pallàs M
Br J Pharmacol; 2021 Aug; 178(15):3017-3033. PubMed ID: 33817786
[TBL] [Abstract][Full Text] [Related]
6. 2-(2-benzofuranyl)-2-imidazoline (2-BFI) improved the impairments in AD rat models by inhibiting oxidative stress, inflammation and apoptosis.
Tian JS; Zhai QJ; Zhao Y; Chen R; Zhao LD
J Integr Neurosci; 2017; 16(4):385-400. PubMed ID: 28891528
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of the imidazoline I2 receptor agonist 2-BFI on oxidative cytotoxicity in astrocytes.
Choi DH; Yun JH; Lee J
Biochem Biophys Res Commun; 2018 Sep; 503(4):3011-3016. PubMed ID: 30143255
[TBL] [Abstract][Full Text] [Related]
8. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
Alemany R; Olmos G; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
[TBL] [Abstract][Full Text] [Related]
9. Exploring the antidepressant-like potential of the selective I
Hernández-Hernández E; García-Sevilla JA; García-Fuster MJ
Pharmacol Rep; 2021 Feb; 73(1):288-295. PubMed ID: 32748254
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the effects of 2-BFI and tracizoline, two potent I
Hernández-Hernández E; García-Fuster MJ
Naunyn Schmiedebergs Arch Pharmacol; 2021 May; 394(5):989-996. PubMed ID: 33415506
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain.
Garau C; Miralles A; García-Sevilla JA
J Psychopharmacol; 2013 Feb; 27(2):123-34. PubMed ID: 22719017
[TBL] [Abstract][Full Text] [Related]
12. Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo.
Sastre-Coll A; Esteban S; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jul; 360(1):50-62. PubMed ID: 10463334
[TBL] [Abstract][Full Text] [Related]
13. Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFI.
Giorgioni G; Ambrosini D; Vesprini C; Hudson A; Nasuti C; Di Stefano A; Sozio P; Ciampi O; Costa B; Martini C; Carrieri A; Carbonara G; Enzensperger C; Pigini M
Bioorg Med Chem; 2010 Oct; 18(19):7085-91. PubMed ID: 20801048
[TBL] [Abstract][Full Text] [Related]
14. Effects of I
Keller B; García-Sevilla JA
Neurochem Int; 2017 Sep; 108():169-176. PubMed ID: 28342965
[TBL] [Abstract][Full Text] [Related]
15. 2-(-2-benzofuranyl)-2-imidazoline induces Bcl-2 expression and provides neuroprotection against transient cerebral ischemia in rats.
Han Z; Zhang HX; Tian JS; Zheng RY; Hou ST
Brain Res; 2010 Nov; 1361():86-92. PubMed ID: 20840843
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and Cognitive Improvement Induced by Novel Imidazoline I
Griñán-Ferré C; Vasilopoulou F; Abás S; Rodríguez-Arévalo S; Bagán A; Sureda FX; Pérez B; Callado LF; García-Sevilla JA; García-Fuster MJ; Escolano C; Pallàs M
Neurotherapeutics; 2019 Apr; 16(2):416-431. PubMed ID: 30460457
[TBL] [Abstract][Full Text] [Related]
17. Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I1- and I2-imidazoline drugs.
Keller B; García-Sevilla JA
J Psychopharmacol; 2015 Sep; 29(9):996-1012. PubMed ID: 26038110
[TBL] [Abstract][Full Text] [Related]
18. Role of intracellular Ca
Siemian JN; Qiu Y; Zhang Y; Li JX
Psychopharmacology (Berl); 2017 Nov; 234(22):3299-3307. PubMed ID: 28825118
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease.
Bagán A; Rodriguez-Arévalo S; Taboada-Jara T; Griñán-Ferré C; Pallàs M; Brocos-Mosquera I; Callado LF; Morales-García JA; Pérez B; Diaz C; Fernández-Godino R; Genilloud O; Beljkas M; Oljacic S; Nikolic K; Escolano C
Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896141
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
